Harish Dureja

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Venues

Current drug delivery

International journal of surgery (London, England)

Future medicinal chemistry

Therapeutic delivery

Maharshi Dayanand University Rohtak

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Maharshi Dayanand University Rohtak Nov 02 2000

India

Professor :: Pharmaceutical Sciences

Publications

Lokesh Nagar, Nisha Gulati, Annu Saini, Sachin Singh, Gaurav Gupta, Ronan MacLoughlin, Dinesh Kumar Chellappan, Kamal Dua, Harish Dureja
Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD). Current drug delivery (2024)
null Lokesh, Nisha Gulati, Annu Saini, Sachin Singh, Gaurav Gupta, Ronan MacLoughlin, Dinesh Kumar Chellappan, Kamal Dua, Harish Dureja
Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD). Current drug delivery (2024)
Manisha Saini, Shailendra Bhatt, Harish Dureja, Neeta Solanki
Recent Patents on Solid Dispersions Emphasize Promising Benefits in Solubility Enhancement of Poorly Water-soluble Drugs. Recent patents on nanotechnology (2023)
Jatin Chhabra, Inderbir Padda, Rakesh Pahwa, Neha Raina, Karan Wadhwa, Swati Saini, Poonam Negi, Madhu Gupta, Inderbir Singh, Harish Dureja, Talhah Bin Emran
Potential of nanoemulsions for accelerated wound healing: innovative strategies. International journal of surgery (London, England) (2023)
Swati Saini, Nisha Gulati, Rajendra Awasthi, Vimal Arora, Sachin Singh, Shobhit Kumar, Gaurav Gupta, Kamal Dua, Rakesh Pahwa, Harish Dureja
Monoclonal antibodies and antibody-drug conjugates as emerging therapeutics for breast cancer treatment. Current drug delivery (2023)
Harpreet Kaur Khanuja, Rajendra Awasthi, Harish Dureja
Sorafenib tosylate-loaded nanosuspension: preparation, optimization, and in vitro cytotoxicity study against human HepG2 carcinoma cells. Journal of chemotherapy (Florence, Italy) (2023)
Jatin Chhabra, Inderbir Padda, Rakesh Pahwa, Neha Raina, Karan Wadhwa, Swati Saini, Poonam Negi, Madhu Gupta, Inderbir Singh, Harish Dureja, Talhah Bin Emran
Potential of nanoemulsions for accelerated wound healing: innovative strategies. International journal of surgery (London, England) (2023)
Jaskiran Kaur, Monica Gulati, Flavia C Zacconi, Harish Dureja, Raimar Löbenberg, Md Salahuddin Ansari, Othman AlOmeir, Aftab Alam, Dinesh Kumar Chellappan, Dinesh Kumar Chellappan, Niraj Kumar Jha, Terezinha de Jesus Andreoli Pinto, Andrew P Morris, Yahya Essop Choonara, Jon Adams, Kamal Dua, Dinesh Kumar Chellapan
Biomedical Applications of polymeric micelles in the treatment of diabetes mellitus: Current success and future approaches. Expert opinion on drug delivery 19 (7) (2022)
Meenu Mehta, Keshav Raj Paudel, Shakti Dhar Shukla, Madhur D Shastri, Saurabh Satija, Dinesh Kumar Chellapan, Monica Gulati, Harish Dureja, Flavia C Zacconi, Philip Michael Hansbro, Dinesh Kumar Chellappan, Kamal Dua
Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: a PCR validation. Future medicinal chemistry 13 (6) (2021)
Seyed H Shahcheraghi, Jamshid Ayatollahi, Alaa A A Aljabali, Madhur D Shastri, Shakti Dhar Shukla, Dinesh Kumar Chellappan, Niraj Kumar Jha, Krishnan Anand, Naresh K Katari, Meenu Mehta, Saurabh Satija, Harish Dureja, Vijay Mishra, Abdulmajeed G Almutary, Abdullah M Alnuqaydan, Nitin Charbe, Parteek Prasher, Kamal Dua, Marzieh Lotfi, Hamid A Bakshi, Murtaza M Tambuwala
An overview of vaccine development for COVID-19. Therapeutic delivery 12 (3) (2021)
Alaa A A Aljabali, Sk Sarif Hassan, Ritesh M Pabari, Seyed H Shahcheraghi, Vijay Mishra, Nitin B Charbe, Dinesh K Chellappan, Harish Dureja, Dinesh Kumar Chellappan, Abdulmajeed G Almutary, Abdullah M Alnuqaydan, Suresh K Verma, Pritam K Panda, Yogendra Kumar Mishra, Ángel Serrano-Aroca, Kamal Dua, Vladimir N Uversky, Elrashdy M Redwan, Bojlul Bahar, Amit Bhatia, Poonam Negi, Rohit Goyal, Paul McCarron, Hamid A Bakshi, Murtaza M Tambuwala
The viral capsid as novel nanomaterials for drug delivery. Future science OA 7 (9) (2021)
Nisha Gulati, Dinesh Kumar Chellappan, Murtaza M Tambuwala, Alaa A A Aljabali, Parteek Prasher, Dinesh Kumar Chellapan, Krishnan Anand, Ankur Sharma, Niraj Kumar Jha, Gaurav Gupta, Kamal Dua, Harish Dureja
Oral Nanoemulsion of Fenofibrate: Formulation, Characterization, and In Vitro Drug Release Studies. Assay and drug development technologies 19 (4) (2021)
Hamid A Bakshi, Mazhar Salim Al Zoubi, Faruck L Hakkim, Alaa A A Aljabali, Firas A Rabi, Amin A Hafiz, Khalid M Al-Batanyeh, Bahaa Al-Trad, Prawej Ansari, Mohamed M Nasef, Nitin B Charbe, Saurabh Satija, Meenu Mehta, Vijay Mishra, Dinesh Kumar Chellappan, Salem Abobaker, Poonam Negi, Ibrahim M Azzouz, Ashref Ali K Dardouri, Harish Dureja, Parteek Prasher, Dinesh Kumar Chellappan, Kamal Dua, Mateus Webba Da Silva, Mohamed El Tanani, Paul A McCarron, Murtaza M Tambuwala
Dietary Crocin is Protective in Pancreatic Cancer while Reducing Radiation-Induced Hepatic Oxidative Damage. Nutrients 12 (6) (2020)
Mousmee Sharma, Parteek Prasher, Meenu Mehta, Flavia C Zacconi, Yogendra Singh, Deepak N Kapoor, Harish Dureja, Dinesh M Pardhi, Murtaza M Tambuwala, Dinesh Kumar Chellappan, Dinesh Kumar Chellappan, Kamal Dua, Saurabh Satija
Probing 3CL protease: Rationally designed chemical moieties for COVID-19. Drug development research (2020)
Neeta Solanki, Meenu Mehta, Dinesh Kumar Chellappan, Nicole G Hansbro, Murtaza M Tambuwala, Alaa A A Aljabali, Keshav Raj Paudel, Gang Liu, Saurabh Satija, Philip Michael Hansbro, Kamal Dua, Harish Dureja
Antiproliferative effects of boswellic acid-loaded chitosan nanoparticles on human lung cancer cell line A549. Future medicinal chemistry 12 (22) (2020)

Harish Dureja.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Harish Dureja